Raju S.  Kucherlapati net worth and biography

Raju Kucherlapati Biography and Net Worth

Raju Kucherlapati, Ph.D., is the Paul C. Cabot Professor in the Harvard Medical School Department of Genetics. He is also a professor in the Department of Medicine at Brigham and Women’s Hospital.

Dr. Kucherlapati was the first Scientific Director of the Harvard Medical School-Partners Healthcare Center for Genetics and Genomics. His research focuses on gene mapping, gene modification, and cloning disease genes. From 1989-2001, Dr. Kucherlapati was the Lola and Saul Kramer Professor of Molecular Genetics and Chairman of the Department at the Yeshiva University Albert Einstein College of Medicine. He was previously a professor in the Department of Genetics at the University of Illinois, College of Medicine. He began his research as an assistant professor in the Department of Biochemical Sciences at Princeton University.

He has chaired numerous NIH committees and served on the National Advisory Council for Human Genome Research and the NCI Mouse Models for Human Cancer Consortium. He is also a member of the Cancer Genome Atlas project of the National Institutes of Health. He is a member of the Institute of Medicine of the National Academy of Sciences and a fellow of the American Association for the Advancement of Science.

Dr. Kucherlapati received his B.S. and M.A. in Biology from universities in India, and he received his Ph.D. from the University of Illinois at Urbana, as well as conducting post-doctoral work at Yale University.

What is Raju S. Kucherlapati's net worth?

The estimated net worth of Raju S. Kucherlapati is at least $2.46 million as of November 18th, 2022. Kucherlapati owns 98,264 shares of Capstar Special Purpose Acquisition stock worth more than $2,462,005 as of December 5th. This net worth estimate does not reflect any other investments that Kucherlapati may own. Learn More about Raju S. Kucherlapati's net worth.

How do I contact Raju S. Kucherlapati?

The corporate mailing address for Kucherlapati and other Capstar Special Purpose Acquisition executives is 405 WEST 14TH STREET, AUSTIN TX, 78701. Capstar Special Purpose Acquisition can also be reached via phone at 512-340-7800 and via email at 0. Learn More on Raju S. Kucherlapati's contact information.

Has Raju S. Kucherlapati been buying or selling shares of Capstar Special Purpose Acquisition?

Raju S. Kucherlapati has not been actively trading shares of Capstar Special Purpose Acquisition during the last quarter. Most recently, on Friday, January 14th, Raju S. Kucherlapati bought 15,000 shares of Capstar Special Purpose Acquisition stock. The stock was acquired at an average cost of $6.67 per share, with a total value of $100,050.00. Learn More on Raju S. Kucherlapati's trading history.

Raju S. Kucherlapati Insider Trading History at Capstar Special Purpose Acquisition

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/14/2022Buy15,000$6.67$100,050.00View SEC Filing Icon  
See Full Table

Raju S. Kucherlapati Buying and Selling Activity at Capstar Special Purpose Acquisition

This chart shows Raju S Kucherlapati's buying and selling at Capstar Special Purpose Acquisition by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Capstar Special Purpose Acquisition Company Overview

Capstar Special Purpose Acquisition logo
Capstar Special Purpose Acquisition Corp. is a blank check company. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the consumer, healthcare, and technology, media and telecommunications industries. The company was incorporated in 2020 and is based Austin, Texas.
Read More

Today's Range

Now: $25.06
Low: $25.06
High: $25.06

50 Day Range

MA: $8.28
Low: $6.53
High: $9.99

2 Week Range

Now: $25.06
Low: $6.06
High: $12.23

Volume

94 shs

Average Volume

556,189 shs

Market Capitalization

$864.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.07